Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Antidepressants plus ’talk therapy’ are effective therapy for teen depression

18.08.2004


But talk therapy alone is no better than placebo

A new study from the Johns Hopkins Children’s Center and 12 other medical centers shows the most effective treatment for adolescents with major depressive disorder is a combination of antidepressants and psychotherapy. Researchers say the study’s findings indicate this combination treatment may be best for both improving depression and reducing the level of suicidal thinking in adolescents.

The multicenter Treatment for Adolescents with Depression Study (TADS) clinical trial, sponsored by the National Institute of Mental Health, is believed to be the first to examine the individual and combined effectiveness of the antidepressant fluoxetine (Prozac) and cognitive behavioral ("talk") therapy in depressed adolescents. The findings are published in the August 18th issue of the Journal of the American Medical Association.



Overall, combined antidepressant and talk therapy treatment yielded the best results, followed by antidepressants alone. However, talk therapy on its own was found to be no more effective than placebo, the researchers say.

"Until this study, there was limited evidence that proved antidepressants were appropriate for use in teenagers with depression," says John Walkup, M.D., a co-author of the study and a child and adolescent psychiatrist at the Johns Hopkins Children’s Center. "Not only do the results support the use of antidepressants for depressed teens, but when used in conjunction with talk therapy, these medications actually provide teens with the best chance to alleviate their depression."

Controversy has surrounded the use of Prozac and similar medications (known as selective serotonin reuptake inhibitors) because of reports that they may lead a small number of teenagers and children to become suicidal. In the current study, researchers found that the level of suicidal thoughts, which had been present in 29 percent of the youths at the beginning of the study, decreased significantly regardless of the treatment received, with the combination of fluoxetine and talk therapy showing the greatest reduction. While no patients committed suicide during the study, there were seven cases of attempted suicide during the treatment phase of the study.

However, Walkup says the development of new suicidal thoughts after starting antidepressant medication is unusual. "As long as youths taking antidepressants are monitored closely by their physicians, I believe the benefits of antidepressants for depressed teens really outweigh the risks. Antidepressants can be a safe and effective treatment for teens with depression, a common condition that can be devastating if left untreated," he says.

During the first 12-week section of the study, 439 youths ages 12 to 17 with moderate to severe depression were randomly assigned to a treatment of either fluoxetine; cognitive behavior therapy, during which a therapist reinforces positive thought patterns and behavior; a combination of fluoxetine and talk therapy; or placebo pills.

Using common psychological scales to measure depression severity, researchers found that 71 percent of teens who received fluoxetine and talk therapy improved with treatment, compared with 60.6 percent who received fluoxetine alone, 43.2 percent who received talk therapy alone, and 34.8 percent who received a placebo treatment.

After 12 weeks, patients who were receiving fluoxetine, talk therapy, or a combination of both continued treatment for two more stages, while those who had not responded to placebos were offered the "active" treatment of their choice. However, results to date include only the first 12 weeks of treatment.

The study was led by John S. March, M.D., M.P.H., from Duke University Medical Center. Other TADS sites include: Johns Hopkins Children’s Center, Carolinas Medical Center, Case Western Reserve University, Children’s Hospital of Philadelphia, Columbia University, University of Nebraska, New York University, University of Chicago and Northwestern University, Cincinnati Children’s Hospital Medical Center, University of Oregon, University of Texas Southwestern and Wayne State University.

Jessica Collins | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>